This is a Validated Antibody Database (VAD) review about human TEAD2, based on 3 published articles (read how Labome selects the articles), using TEAD2 antibody in all methods. It is aimed to help Labome visitors find the most suited TEAD2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TEAD2 synonym: ETF; TEAD-2; TEF-4; TEF4; transcriptional enhancer factor TEF-4; TEA domain family member 2

LifeSpan Biosciences
rabbit polyclonal
  • western blot; human; 1:1000
LifeSpan Biosciences TEAD2 antibody (Lifespan, LS-C119063) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human
  • western blot; human
LifeSpan Biosciences TEAD2 antibody (Lifespan Biosciences, LS-C119063) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
MilliporeSigma
rabbit polyclonal
  • western blot; human; loading ...; fig s1b
MilliporeSigma TEAD2 antibody (Sigma-Aldrich, SAB2102402) was used in western blot on human samples (fig s1b). Oncogene (2017) ncbi
Articles Reviewed
  1. Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530 pubmed publisher
  2. Xia Y, Zhang Y, Yu C, Chang T, Fan H. YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells. PLoS ONE. 2014;9:e109575 pubmed publisher
  3. Xia Y, Chang T, Wang Y, Liu Y, Li W, Li M, et al. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. PLoS ONE. 2014;9:e91770 pubmed publisher